SHOEI-SHEN WANGRON-BIN HSUYIH-SHARNG CHENKo W.-J.NAI-KUAN CHOUHSI-YU YUChu S.-H.Liau C.-S.Lee Y.-T.2021-05-062021-05-0620030041-1345https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037319049&doi=10.1016%2fS0041-1345%2802%2903985-4&partnerID=40&md5=172a742577b581c2f612932dbf0ba2bbhttps://scholars.lib.ntu.edu.tw/handle/123456789/559979[SDGs]SDG3aciclovir; adrenalin; alpha interferon; cyclosporin; dobutamine; dopamine; ganciclovir; immunoglobulin; immunosuppressive agent; methylprednisolone; milrinone; mycophenolic acid 2 morpholinoethyl ester; OKT 3; tacrolimus; acute graft rejection; adolescent; artery occlusion; body weight; child; clinical article; clinical feature; conference paper; congenital heart disease; coronary artery aneurysm; cytomegalovirus infection; disease association; Epstein Barr virus; extracorporeal oxygenation; female; follow up; graft failure; graft rejection; heart dilatation; heart failure; heart left ventricle ejection fraction; heart transplantation; human; human tissue; hypertrophic cardiomyopathy; infant; left anterior descending coronary artery; lymphoproliferative disease; male; maximum permissible dose; mitral valve replacement; mucocutaneous lymph node syndrome; multiple organ failure; organ donor; orthotopic transplantation; physical examination; priority journal; reoperation; survival rate; survival timeconference paper10.1016/S0041-1345(02)03985-4125914882-s2.0-0037319049